PATENT CLAIM ANALYSIS

Application Number: 16146237
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "490000"]

Abstract:
The present invention provides a modified release formulation of lacosamide. The modified release formulation of the present invention comprising lacosamide and modified release polymer provides modified release of lacosamide with minimal C max  to C min  peak to trough variation over a period of at least 12 hrs.

Claim (Index 26):
A modified release formulation of  claim 25 , wherein the modified release formulation is administered in dose range of 100-600 mg of lacosamide.

Metadata:
- Claim Count in Document: 107.0
- Percentile: 97.0
- Lexical Diversity: 1.66667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13990861', '11897940', '12144453', '13980744', '11583888']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7300089478980606
- 35 USC 102 Novelty (BERT): 0.508686448652091
- Combined Prediction Score: 0.7078766979734636
- Mean Citation Score: 203.13612200000003
- Max Citation Score: 254.22932000000003
- Similarity Product: 167.45266761445046

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test